PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride) by Aspiro Therapeutics is alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. First approved in 2013.
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
Phenylephrine hydrochloride is an alpha-1 adrenergic receptor agonist administered as an ophthalmic solution for pupil dilation. It works by constricting ophthalmic blood vessels and contracting the radial muscle of the iris, producing potent vasoconstrictor and mydriatic effects. This small-molecule eye drop is used primarily in diagnostic and surgical ophthalmology procedures.
Product is in peak commercial phase with established market presence; brand team likely optimized but finite in size given ophthalmic specialty segment.
alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. Phenylephrine possesses predominantly α-adrenergic effects. In the eye, phenylephrine acts locally as a potent vasoconstrictor and mydriatic, by constricting ophthalmic blood vessels…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu
Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Worked on PHENYLEPHRINE HYDROCHLORIDE at Aspiro Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moThis product offers limited direct linked job opportunities, reflecting its specialty ophthalmic status and narrow, stable indication. Career roles are concentrated in commercial and medical affairs, with emphasis on maintaining market position in a well-defined physician audience rather than driving expansion.